Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Geroscience|January 12, 2026
The aging gut-glia-immune axis in alzheimer's disease: microbiome-derived mediators of neuroinflammation and therapeutic innovationPrince Ahad Mir, Nishant Kumar, Gyamcho Tshering Bhutia, et al.
Frontiers in Oncology|October 10, 2025
Therapeutic innovations in triple negative breast cancer: integrating molecular targeting and monoclonal antibody strategiesPrince Ahad Mir, Nishant Kumar, Sukesh K Gupta, et al.
ACS Omega|November 6, 2023
Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer's Disease: Understanding the Neurotoxic Mechanisms for Therapeutic InterventionAbdul Jalil Shah, Prince Ahad Mir, Mohd Adnan, et al.
Current Stem Cell Research & Therapy|January 6, 2025
Immunomodulatory Roles of Mesenchymal Stem Cell-derived Extracellular Vesicles: A Promising Therapeutic Approach for Autoimmune DiseasesPrince Ahad Mir, Md Sadique Hussain, Murtaza Ahmad Khanday, et al.
Molecular Neurobiology|June 22, 2026
Reprogramming Neuroinflammation: Mitochondrial Targets and Immune Checkpoint Inhibitors in Alzheimer's DiseaseNishant Kumar, Prince Ahad Mir, Gyamcho Tshering Bhutia, et al.
Metabolites|April 28, 2023
Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer TherapeuticsReyaz Hassan Mir, Prince Ahad Mir, Jasreen Uppal, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 7, 2021
Bioactive Heterocyclic Compounds as Potential Therapeutics in the Treatment of Gliomas: A ReviewReyaz Hassan, Roohi Mohi-Ud-Din, Mohammad Ovais Dar, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 13, 2022
Anticancer Potential of Thymoquinone: A Novel Bioactive Natural Compound from <i>Nigella sativa</i> LPrince Ahad Mir, Roohi Mohi-Ud-Din, Nazia Banday, et al.
Current Pharmaceutical Design|May 10, 2024
Green Synthesis of Silver Nanoparticles and their Potential Applications in Mitigating CancerReyaz Hassan Mir, Mudasir Maqbool, Prince Ahad Mir, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Therapeutic ImplicationsAdil Farooq Wali, Abid Reza Ansari, Prince Ahad Mir, et al.
Pageof 2